Immune checkpoint inhibitors and the kidney: A focus on diagnosis and management for personalised medicine
E Longhitano, P Muscolino, C Lo Re, SA Ferrara… - Cancers, 2023 - mdpi.com
Simple Summary Immune-oncology has revolutionized the natural history of many cancers
in the past decade, becoming a new therapeutic weapon. The identification of immune …
in the past decade, becoming a new therapeutic weapon. The identification of immune …
How to deal with renal toxicities from immune-based combination treatments in metastatic renal cell carcinoma. A nephrological consultation for Oncologists
T Marcello, C Laura, P Marta, C Ilaria… - Cancer Treatment …, 2024 - Elsevier
We are witnessing a revolution in the treatment of metastatic renal cell carcinoma (mRCC).
Indeed, several immune-based combinations (ICI [immune checkpoint inhibitor]+ ICI, or ICI+ …
Indeed, several immune-based combinations (ICI [immune checkpoint inhibitor]+ ICI, or ICI+ …
Frequency and characteristics of chemotherapy‐associated thrombotic microangiopathy: Analysis from a large pharmacovigilance database
To the Editor, Thrombotic microangiopathies (TMAs) are a heterogenous group of rare, yet
life-threatening disorders that are characterized by hemolytic anemia, thrombocytopenia …
life-threatening disorders that are characterized by hemolytic anemia, thrombocytopenia …
Therapeutic plasma exchange in the management of immune checkpoint inhibitor‐associated immune‐related adverse effects: A review.
OA Onwuemene, CI Nnoruka, CJ Patriquin… - …, 2022 - search.ebscohost.com
TPE in the treatment of limbic encephalitis Four studies describe TPE treatment for limbic
encephalitis. 70-73 The largest case series includes 19 patients in which TPE was used in …
encephalitis. 70-73 The largest case series includes 19 patients in which TPE was used in …
The histomorphology of the senescent kidney–the clinical relevance of specimen and biopsy findings in the elderly native kidneys
N Kozakowski - Current Opinion in Urology, 2024 - journals.lww.com
Ageing-or senescence-related changes in elderly kidneys, the processes of growing old or,
respectively, cell degeneration by arrested cell growth, combine and result in scarring in …
respectively, cell degeneration by arrested cell growth, combine and result in scarring in …
A brief review of renal-limited thrombotic microangiopathy associated with immune checkpoint inhibitors
SH Kwak, CV Shah - Journal of Onco-Nephrology, 2023 - journals.sagepub.com
As a rare immune-mediated adverse reaction to immune checkpoint inhibitor (ICI) therapy,
immune checkpoint inhibitor associated renal-limited thrombotic microangiopathy (ICI-rTMA) …
immune checkpoint inhibitor associated renal-limited thrombotic microangiopathy (ICI-rTMA) …
Management Update in Immunotherapy and Kidney Injury
C Garcia-Carro, F Gonçalves, MJ Soler, S Bermejo - 2024 - Springer
In the last decade, immunotherapy has become the cornerstone for treating patients with
cancer and metastases. However, these new treatments have been associated with immune …
cancer and metastases. However, these new treatments have been associated with immune …
[HTML][HTML] Renal-Limited Thrombotic Microangiopathy in a Patient Who Received Gemcitabine, Ramucirumab, and Pembrolizumab: A Case Report and Literature …
SS Patel, HY Shan - Cureus, 2024 - ncbi.nlm.nih.gov
Cancer drug-induced thrombotic microangiopathy (DITMA) is an important and serious
cause of kidney disease in cancer patients. In addition to classical chemotherapy, the …
cause of kidney disease in cancer patients. In addition to classical chemotherapy, the …
[PDF][PDF] Fracaso renal agudo y síndrome nefrótico en paciente oncológico
IM Toral, AS González, FJD Crespo… - 2023 - revistanefrologia.com
Los pacientes oncológicos pueden presentar fracaso renal agudo (FRA) por una gran
variedad de causas (tabla 1), pero cuando este se presenta en asociación con proteinuria o …
variedad de causas (tabla 1), pero cuando este se presenta en asociación con proteinuria o …
A Case of St-Segment Elevation Myocardial Infarction and Thrombocytopenia Induced by Immune Checkpoint Inhibitor Sintilimab
L Guo, Y Chang - Available at SSRN 4342368 - papers.ssrn.com
Abstract Introduction: Immune checkpoint inhibitors (ICIs) have been widely applied in non-
small cell lung cancer (NSCLC) patients. Immune-related cardiovascular and hematologic …
small cell lung cancer (NSCLC) patients. Immune-related cardiovascular and hematologic …